Charles Schwab’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.8M | Sell |
235,015
-7,243
| -3% | -$148K | ﹤0.01% | 2349 |
|
|
2025
Q1 | $4.85M | Sell |
242,258
-16,608
| -6% | -$332K | ﹤0.01% | 2284 |
|
|
2024
Q4 | $6.9M | Sell |
258,866
-15,895
| -6% | -$424K | ﹤0.01% | 2181 |
|
|
2024
Q3 | $7.84M | Buy |
274,761
+39,417
| +17% | +$1.12M | ﹤0.01% | 2156 |
|
|
2024
Q2 | $5.12M | Buy |
235,344
+30,407
| +15% | +$662K | ﹤0.01% | 2349 |
|
|
2024
Q1 | $4.54M | Sell |
204,937
-2,358
| -1% | -$52.2K | ﹤0.01% | 2324 |
|
|
2023
Q4 | $4.47M | Buy |
207,295
+6,306
| +3% | +$136K | ﹤0.01% | 2357 |
|
|
2023
Q3 | $3.39M | Buy |
200,989
+14,994
| +8% | +$253K | ﹤0.01% | 2423 |
|
|
2023
Q2 | $2.55M | Buy |
185,995
+2,329
| +1% | +$32K | ﹤0.01% | 2476 |
|
|
2023
Q1 | $4.17M | Sell |
183,666
-870
| -0.5% | -$19.8K | ﹤0.01% | 2286 |
|
|
2022
Q4 | $4.34M | Buy |
184,536
+6,910
| +4% | +$163K | ﹤0.01% | 2289 |
|
|
2022
Q3 | $4.63M | Buy |
177,626
+6,585
| +4% | +$172K | ﹤0.01% | 2249 |
|
|
2022
Q2 | $3.76M | Buy |
171,041
+4,928
| +3% | +$108K | ﹤0.01% | 2307 |
|
|
2022
Q1 | $7.45M | Buy |
166,113
+4,198
| +3% | +$188K | ﹤0.01% | 2093 |
|
|
2021
Q4 | $6.94M | Buy |
161,915
+3,492
| +2% | +$150K | ﹤0.01% | 2187 |
|
|
2021
Q3 | $10.5M | Buy |
158,423
+25,170
| +19% | +$1.67M | ﹤0.01% | 1977 |
|
|
2021
Q2 | $9.77M | Buy |
133,253
+16,606
| +14% | +$1.22M | ﹤0.01% | 2015 |
|
|
2021
Q1 | $7.99M | Buy |
116,647
+11,595
| +11% | +$794K | ﹤0.01% | 2072 |
|
|
2020
Q4 | $7.06M | Buy |
105,052
+19,526
| +23% | +$1.31M | ﹤0.01% | 2051 |
|
|
2020
Q3 | $4.4M | Buy |
85,526
+62,304
| +268% | +$3.21M | ﹤0.01% | 2125 |
|
|
2020
Q2 | $876K | Buy |
23,222
+620
| +3% | +$23.4K | ﹤0.01% | 2658 |
|
|
2020
Q1 | $674K | Buy |
22,602
+12,267
| +119% | +$366K | ﹤0.01% | 2603 |
|
|
2019
Q4 | $356K | Buy |
+10,335
| New | +$356K | ﹤0.01% | 2932 |
|